Cancer drug resistance is a serious threat in Bangladesh

Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi

PDF(457 KB)
PDF(457 KB)
Intelligent Pharmacy ›› 2024, Vol. 2 ›› Issue (5) : 742-743. DOI: 10.1016/j.ipha.2024.01.013

Cancer drug resistance is a serious threat in Bangladesh

Author information +
History +

Abstract

Cancer drug resistance is a serious issue in Bangladesh that must be addressed with effective solutions. The growth of resistant bacterial strains, inappropriate use of antimicrobials, and inadequate healthcare standards in Bangladesh have resulted in a severe problem with cancer medication resistance. A comprehensive strategy will be needed to address these problems, one that includes expanding knowledge of antibiotic resistance, bettering healthcare system regulation, and developing more potent cancer therapies.

Keywords

Cancer / Cancer drug resistance / Bangladesh

Cite this article

Download citation ▾
Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi. Cancer drug resistance is a serious threat in Bangladesh. Intelligent Pharmacy, 2024, 2(5): 742‒743 https://doi.org/10.1016/j.ipha.2024.01.013

References

[1]
Uddin AK, Sumon MA, Pervin S, Sharmin F. Cervical cancer in Bangladesh. South Asian J Cancer. 2023;12(1):36–38.
CrossRef Google scholar
[2]
Hussain SMA. Comprehensive update on cancer scenario of Bangladesh. South Asian J Cancer. 2013;2(4):279–284.
CrossRef Google scholar
[3]
www.who.int/publications/m/item/cancer-bgd-2020.
[4]
gco.iarc.fr/today/data/factsheets/populations/50-bangladesh-fact-sheets.pdf.
[5]
Emran TB, Shahriar A, Mahmud AR, et al. Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front Oncol. 2022;12:891652.
CrossRef Google scholar
[6]
Hoque R, Ahmed SM, Naher N, et al. Tackling antimicrobial resistance in Bangladesh: a scoping review of policy and practice in human, animal and environment sectors. PLoS One. 2020;15(1):e0227947.
CrossRef Google scholar
[7]
Farhan M. Insights on the Role of polyphenols in combating cancer drug resistance. Biomedicine. 2023;11(6):1709.
CrossRef Google scholar
[8]
Khan FA, Salim MH, du Cros P, et al. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses. Eur Respir J. 2017;50(1).
CrossRef Google scholar

RIGHTS & PERMISSIONS

2024 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
AI Summary AI Mindmap
PDF(457 KB)

Accesses

Citations

Detail

Sections
Recommended

/